397 related articles for article (PubMed ID: 23648880)
1. Bivalirudin in pediatric patients maintained on extracorporeal life support.
Nagle EL; Dager WE; Duby JJ; Roberts AJ; Kenny LE; Murthy MS; Pretzlaff RK
Pediatr Crit Care Med; 2013 May; 14(4):e182-8. PubMed ID: 23648880
[TBL] [Abstract][Full Text] [Related]
2. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
[TBL] [Abstract][Full Text] [Related]
3. Correlation of bivalirudin dose with creatinine clearance during treatment of heparin-induced thrombocytopenia.
Runyan CL; Cabral KP; Riker RR; Redding D; May T; Seder DB; Savic M; Hedlund J; Abramson S; Fraser GL
Pharmacotherapy; 2011 Sep; 31(9):850-6. PubMed ID: 21923585
[TBL] [Abstract][Full Text] [Related]
4. Is anticoagulation with bivalirudin comparable to heparin for pediatric extracorporeal life support? Results from a high-volume center.
Schill MR; Douds MT; Burns EL; Lahart MA; Said AS; Abarbanell AM
Artif Organs; 2021 Jan; 45(1):15-21. PubMed ID: 32557733
[TBL] [Abstract][Full Text] [Related]
5. Prospective Exploratory Experience With Bivalirudin Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation.
Ryerson LM; Balutis KR; Granoski DA; Nelson LR; Massicotte MP; Lequier LL; Bauman ME
Pediatr Crit Care Med; 2020 Nov; 21(11):975-985. PubMed ID: 32976347
[TBL] [Abstract][Full Text] [Related]
6. Bivalirudin for Alternative Anticoagulation in Extracorporeal Membrane Oxygenation: A Systematic Review.
Sanfilippo F; Asmussen S; Maybauer DM; Santonocito C; Fraser JF; Erdoes G; Maybauer MO
J Intensive Care Med; 2017 Jun; 32(5):312-319. PubMed ID: 27356945
[TBL] [Abstract][Full Text] [Related]
7. Description of Bivalirudin Use for Anticoagulation in Pediatric Patients on Mechanical Circulatory Support.
Campbell CT; Diaz L; Kelly B
Ann Pharmacother; 2021 Jan; 55(1):59-64. PubMed ID: 32590908
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
[TBL] [Abstract][Full Text] [Related]
9. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P
J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330
[TBL] [Abstract][Full Text] [Related]
10. Bivalirudin Dosing Requirements in Adult Patients on Extracorporeal Life Support With or Without Continuous Renal Replacement Therapy.
Walker EA; Roberts AJ; Louie EL; Dager WE
ASAIO J; 2019 Feb; 65(2):134-138. PubMed ID: 29538017
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation for critically ill cardiac surgery patients: is primary bivalirudin the next step?
Pappalardo F; Agracheva N; Covello RD; Pieri M; De Bonis M; Calabrò MG; Koster A; Zangrillo A
J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1013-17. PubMed ID: 24447496
[TBL] [Abstract][Full Text] [Related]
12. Bivalirudin anticoagulation for left ventricular assist device implantation on an extracorporeal life support system in patients with heparin-induced thrombocytopenia antibodies.
Ljajikj E; Zittermann A; Morshuis M; Börgermann J; Ruiz-Cano M; Schoenbrodt M; Gummert J; Koster A
Interact Cardiovasc Thorac Surg; 2017 Dec; 25(6):898-904. PubMed ID: 29049666
[TBL] [Abstract][Full Text] [Related]
13. Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO).
Kaushik S; Derespina KR; Chandhoke S; Shah DD; Cohen T; Shlomovich M; Medar SS; Peek GJ
Perfusion; 2023 Jan; 38(1):58-65. PubMed ID: 34318718
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Bivalirudin As an Alternative to Heparin for Systemic Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation.
Hamzah M; Jarden AM; Ezetendu C; Stewart R
Pediatr Crit Care Med; 2020 Sep; 21(9):827-834. PubMed ID: 32404633
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation.
Seelhammer TG; Bohman JK; Schulte PJ; Hanson AC; Aganga DO
Crit Care Med; 2021 Sep; 49(9):1481-1492. PubMed ID: 33870916
[TBL] [Abstract][Full Text] [Related]
16. Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.
Kiser TH; Burch JC; Klem PM; Hassell KL
Pharmacotherapy; 2008 Sep; 28(9):1115-24. PubMed ID: 18752382
[TBL] [Abstract][Full Text] [Related]
17. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy.
Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A
Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056
[TBL] [Abstract][Full Text] [Related]
18. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy.
Kiser TH; MacLaren R; Fish DN; Hassell KL; Teitelbaum I
Pharmacotherapy; 2010 Nov; 30(11):1117-26. PubMed ID: 20973685
[TBL] [Abstract][Full Text] [Related]
19. Successful use and dosing of bivalirudin after temporary total artificial heart implantation: a case series.
Crouch MA; Kasirajan V; Cahoon W; Katlaps GJ; Gunnerson KJ
Pharmacotherapy; 2008 Nov; 28(11):1413-20. PubMed ID: 18957002
[TBL] [Abstract][Full Text] [Related]
20. Bivalirudin for anticoagulation in children.
Rayapudi S; Torres A; Deshpande GG; Ross MP; Wohrley JD; Young G; Tarantino MD
Pediatr Blood Cancer; 2008 Dec; 51(6):798-801. PubMed ID: 18819124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
